Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DORIA

Showing results (341-350 of 667) with videos related to

Pageof 67
Sort By:
Physical Review Letters|December 23, 2022
Stable Operation of a Free-Electron Laser Driven by a Plasma AcceleratorM Galletti, D Alesini, M P Anania, et al.
Science (New York, N.Y.)|May 14, 2016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyRui Kong, Kai Xu, Tongqing Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron NeutralizationNicole A Doria-Rose, Xiaoying Shen, Stephen D Schmidt, et al.
Cell Host & Microbe|March 5, 2020
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing LineageChen-Hsiang Shen, Brandon J DeKosky, Yicheng Guo, et al.
Nature|May 25, 2022
Free-electron lasing with compact beam-driven plasma wakefield acceleratorR Pompili, D Alesini, M P Anania, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
Journal of Virology|April 26, 2023
Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV NeutralizationMallika Sastry, Anita Changela, Jason Gorman, et al.
Cell Reports|July 12, 2023
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptideShuishu Wang, Flavio Matassoli, Baoshan Zhang, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
The Lancet. HIV|September 2, 2019
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trialMartin R Gaudinski, Katherine V Houser, Nicole A Doria-Rose, et al.
Pageof 67

Showing results (341-350 of 667) with videos related to

Sort By:
Pageof 67
Physical Review Letters|December 23, 2022
Stable Operation of a Free-Electron Laser Driven by a Plasma AcceleratorM Galletti, D Alesini, M P Anania, et al.
Science (New York, N.Y.)|May 14, 2016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyRui Kong, Kai Xu, Tongqing Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron NeutralizationNicole A Doria-Rose, Xiaoying Shen, Stephen D Schmidt, et al.
Cell Host & Microbe|March 5, 2020
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing LineageChen-Hsiang Shen, Brandon J DeKosky, Yicheng Guo, et al.
Nature|May 25, 2022
Free-electron lasing with compact beam-driven plasma wakefield acceleratorR Pompili, D Alesini, M P Anania, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
Journal of Virology|April 26, 2023
Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV NeutralizationMallika Sastry, Anita Changela, Jason Gorman, et al.
Cell Reports|July 12, 2023
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptideShuishu Wang, Flavio Matassoli, Baoshan Zhang, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
The Lancet. HIV|September 2, 2019
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trialMartin R Gaudinski, Katherine V Houser, Nicole A Doria-Rose, et al.
Pageof 67